DiaMedica Therapeutics Inc.
$7.64
The Read: DiaMedica’s stock has historically rallied on capital raises and cash runway confirmations that eased liquidity concerns but then declined when clinical trial progress and pipeline updates failed to meet investor expectations.
Price
Overlays
Panel
DMAC
Hover to view data
No Data